Adoptive immunotherapy of a newly induced sarcoma: immunologic characteristics of effector cellsSUYU SHU; ROSENBERG, S. A.The Journal of immunology (1950). 1985, Vol 135, Num 4, pp 2895-2903, issn 0022-1767Article

Adoptive immunotherapy of intracranial tumors by systemic transfer of tumor-draining lymph node cellsPLAUTZ, G. E; SUYU SHU.International journal of oncology. 1997, Vol 11, Num 2, pp 389-395, issn 1019-6439Article

Cellular interactions and the role of interleukin 2 in the expression and induction of immunity against a syngeneic murine sarcomaCHOU, T; SUYU SHU.The Journal of immunology (1950). 1987, Vol 139, Num 6, pp 2103-2109, issn 0022-1767Article

BULLONS DISEASE OF CHILDHOOD. REPORT OF A CASE DEMONSTRATING ANTIBASAL CELL ANTIBODY.SHMUNES E; SUYU SHU.1977; ARCH. DERMATOL.; U.S.A.; DA. 1977; VOL. 113; NO 3; PP. 325-327; BIBL. 11 REF.Article

Host lymphodepletion augments T cell adoptive immunotherapy through enhanced intratumoral proliferation of effector cellsWANG, Li-Xin; SUYU SHU; PLAUTZ, Gregory E et al.Cancer research (Baltimore). 2005, Vol 65, Num 20, pp 9547-9554, issn 0008-5472, 8 p.Article

Generation from tumor-bearing mice of lymphocytes with in vivo therapeutic efficacySUYU SHU; CHOU, T; ROSENBERG, S. A et al.The Journal of immunology (1950). 1987, Vol 139, Num 1, pp 295-304, issn 0022-1767Article

In vitro sensitization and expansion with viable tumor cells and interleukin 2 in the generation of specific therapeutic effector cellsSUYU SHU; CHOU, T; ROSENBERG, S. A et al.The Journal of immunology (1950). 1986, Vol 136, Num 10, pp 3891-3898, issn 0022-1767Article

Tumor-specific granulocyte/macrophage colony-stimulating factor and interferon γ secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cellsARUGA, A; SUYU SHU; CHANG, A. E et al.Cancer immunology and immunotherapy. 1995, Vol 41, Num 5, pp 317-324, issn 0340-7004Article

Therapeutic efficacy of adoptive immunotherapy is predicated on in vivo antigen-specific proliferation of donor T cellsKJAERGAARD, Jørgen; LIAOMIN PENG; COHEN, Peter A et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 108, Num 1, pp 8-20, issn 1521-6616, 13 p.Article

Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumorMATSUMURA, T; KRINOCK, R. A; CHANG, A. E et al.Cancer research (Baltimore). 1993, Vol 53, Num 18, pp 4315-4321, issn 0008-5472Article

In vivo antitumor efficacy of tumor-draining lymph node cells activated with nonspecific T-cell reagentsSUYU SHU; SUSSMAN, J. J; CHANG, A. E et al.Journal of immunotherapy. 1993, Vol 14, Num 4, pp 279-285, issn 1053-8550Conference Paper

Suppressive effects of visceral tumor on the generation of antitumor T cells for adoptive immunotherapySOUDAK, V. K; SUYU SHU, W; CHANG, A. E et al.Archives of surgery (Chicago, IL. 1960). 1991, Vol 126, Num 4, pp 442-446, issn 0004-0010Conference Paper

Therapeutic efficacy of Th1 and Th2 L-selectin : CD4+ tumor-reactive T cellsTO, Wyatt C; SEELEY, Brook M; BARTHEL, Steven W et al.The Laryngoscope. 2000, Vol 110, Num 10, pp 1648-1654, issn 0023-852X, 1Conference Paper

INCIDENCE AND TITERS OF ANTINUCLEAR, ANTISMOOTH MUSCLE, AND OTHER AUTOANTIBODIES IN BLOOD DONORS.SUYU SHU; NISENGARD RJ; HALE WL et al.1975; J. LAB. CLIN. MED.; U.S.A.; DA. 1975; VOL. 86; NO 2; PP. 259-265; BIBL. 12 REF.Article

NUCLEAR DEPOSITS OF IMMUNOGLOBULINS IN SKIN OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.SUYU SHU; PROVOST T; CROSDALE MB et al.1977; CLIN. EXPER. IMMUNOL.; G.B.; DA. 1977; VOL. 27; NO 2; PP. 238-244; BIBL. 23 REF.Article

Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction moleculesJUN LIU; FINKE, J; KRAUSS, J. C et al.Cancer immunology and immunotherapy. 1998, Vol 46, Num 5, pp 268-276, issn 0340-7004Article

Secretion of both IL-2 and IL-4 by tumor cells results in rejection and immunitySTROME, S. E; CHANG, A. E; SUYU SHU et al.Journal of immunotherapy with emphasis on tumor immunology. 1996, Vol 19, Num 1, pp 21-32, issn 1067-5582Article

Generation of T-cells reactive to the poorly immunogenic B16-BL6 melanoma with efficacy in the treatment of spontaneous metastasesGEIGER, J. D; WAGNER, P. D; CAMERON, M. J et al.Journal of immunotherapy. 1993, Vol 13, Num 3, pp 153-165, issn 1053-8550Article

Differences in the effects of host suppression on the adoptive immunotherapy of subcutaneous and visceral tumorsCHANG, A. E; SUYU SHU; CHOU, T et al.Cancer research (Baltimore). 1986, Vol 46, Num 7, pp 3426-3430, issn 0008-5472Article

Everolimus (RAD) inhibits In vivo growth of murine squamous cell carcinoma (SCC VII)KHARIWALA, Samir S; KJAERGAARD, Jorgen; LORENZ, Robert et al.The Laryngoscope. 2006, Vol 116, Num 5, pp 814-820, issn 0023-852X, 7 p.Article

Adoptive immunotherapy of murine intracerebral tumors with anti-CD3/interleukin-2 activated tumor-draining lymph node cellsWAHL, W. L; SUSSMAN, J. J; SUYU SHU et al.Journal of immunotherapy. 1994, Vol 15, Num 4, pp 242-250, issn 1053-8550Article

Development of antitumor reactivity in regional draining lymph nodes from tumor-immunized and tumor-bearing murine hostsSTEPHENSON, K. R; PERRY-LALLEY, D; GRIFFITH, K. D et al.Surgery. 1989, Vol 105, Num 4, pp 523-528, issn 0039-6060Article

Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from s syngeneic murine sarcomaWARD, B. D; SUYU SHU; CHOU, T et al.The Journal of immunology (1950). 1988, Vol 141, Num 3, pp 1047-1053, issn 0022-1767Article

Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2MULE, J. J; SUYU SHU; SCHWARZ, S. L et al.Science (Washington, D.C.). 1984, Vol 225, Num 4669, pp 1487-1489, issn 0036-8075Article

RAD inhibition of sarcoma growth : implications for laryngeal transplantationKNOTT, Philip Daniel; TAMAI, Hidemasa; STROME, Marshall et al.American journal of otolaryngology. 2007, Vol 28, Num 6, pp 375-378, issn 0196-0709, 4 p.Article